Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1373640Generated: October 30, 2026

Sodium triacetoxyborohydride → 7-{4-[4-(2-Trifluoromethyl-3H-benzoimidazol-4-yl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-one

https://huagongshe.com/reaction/1373640

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium triacetoxyborohydrideHCID 5049666—
Reactant4-(piperazin-1-yl)-2-(trifluoromethyl)-1H-benzo[d]imidazoleHCID 18414107—
Reactant4-((7-Oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)oxy)butanalHCID 21073377—
Solvent1,1-DichloroethaneHCID 6365—
SolventEthyl AcetateHCID 8857—
Product7-{4-[4-(2-Trifluoromethyl-3H-benzoimidazol-4-yl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-oneHCID 17851565635.7%

Reaction Steps

To a suspension of 4-(7-oxo-5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yloxy)-butyraldehyde (0.297 g, 1.266 mmol, 1.32 eq) and 4-piperazin-1-yl-2-trifluoromethyl-1H-benzoimidazole (0.258 g, 0.953 mmol, 1 eq) in dichloroethane (5 mL) was added NaBH(OAc)3 (0.723 g, 3.413 mmol, 3.58 eq). The slurry was allowed to stir overnight at room temperature (18 h). Analysis by HPLC showed reaction mostly complete. The mixture was diluted with Ethyl Acetate and quenched with saturated NaHCO3. The organic phase was then washed with brine, dried over Na2SO4, filtered and evaporated in vacuo. Purification by silica gel chromatography (2% MeOH/CH2Cl2) followed by formation of the HCl salt using 1N HCl in ether provided the title compound (0.166 g, 35%). MS: APCI: M+1: 489.2 (Exact Mass: 488.21).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07160888B2
Source datasetuspto-grants-2007_01
ORD IDord-b201846427c347308ae82dd464ff81bd
Source noteuspto-grants-2007_01